Evidence Synthesis
The Indian equity market witnessed a significant shift in the overnight trading session, with SHILPAMED experiencing substantial gains.
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 18 Sept 2026, 04:33
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
The Indian equity market witnessed a significant shift in the overnight trading session, with SHILPAMED experiencing substantial gains.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 69.35 % | 21.7 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 21.7 % | 17.67 | ▲ |
| REVENUE_GROWTH_YOY | 44.9 % | 115.4 | ▼ |
| EPS_ACTUAL | 2.25 INR | 2.859 | ▼ |
| EPS_SURPRISE_PERCENT | -0.489 % | 0.021 | ▼ |
| PRICE_CHANGE_PERCENT | 3.265 % | — | - |
| DAILY_VOLUME | 8,19,676 shares | 18,14,939 | ▼ |
| CLOSE_PRICE | 958.35 INR | 928.05 | ▲ |
| NEWS_SENTIMENT_SCORE | 1 score | — | - |
| ANALYST_STRONG_BUY_COUNT | 0 count | 4 | ▼ |
| TARGET_PRICE_PREMIUM | -8.05 % | — | - |